About VCapital
VCapital is a venture capital firm founded in 2015. It is primarily based out of Chicago, United States. As of Jun 2026, VCapital has invested in 24 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from High Tech to Enterprise Applications and Life Sciences. Most recently it participated in the $***** Series A round of Rejuvenate Bio Overall, VCapital portfolio has seen 1 unicorn, 3 IPOs and 7 acquisitions including key companies like AOL, Lookout and Intensity Therapeutics. A lot of funds co-invest with VCapital, with names like KdT Ventures sharing a substantial percentage of its portfolio. VCapital has team of 7 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B & 2 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
Deals in last 12 months
VCapital's List of Top Investments
VCapital has a portfolio of 24 companies, one of which is a Unicorn. Their most notable investments are in Rejuvenate Bio and Rejuvenate Bio.Their portfolio spans across United States and China. They have invested in High Tech, Enterprise Applications, Life Sciences and 11 other sectors, across stages such as Series A, Series B and 2 more. Here is the list of top investments by VCapital:1. AOL
Provider of a news aggregation platform with customizable content feeds. The platform delivers news, sports, finance, and entertainment content. It offers users the ability to personalize their news feeds. The platform also provides weather updates and trending topics.
Key facts about AOL
- Founded Year: 1983
- Location: United States
- Annual Revenue: $1B+ as on Dec 31, 2014
- Last Known Valuation: $*****
- Stage: Acquired
- Total Funding till date: $20M
- Employee Count: 3,568 as on Jun 30, 2026
- Investors: Atlas Venture, Batterson Venture Capital and 6 Others
- Latest Funding Round: Series B, Jan 18, 2000, $*****
- Highlight: Acquired
2. Lookout
Provider of mobile endpoint security solutions against phishing and malware. It offers protection against phishing attacks, SMS-based phishing, and executive impersonation. The company provides mobile endpoint security, mobile EDR, and mobile app reputation services. It scans devices for vulnerabilities, tracks CVEs, and enforces updates. The company delivers actionable security insights about mobile devices, apps, and users. It integrates mobile risk data into security ecosystems.
Key facts about Lookout
- Founded Year: 2007
- Location: San Francisco (United States)
- Valuation: $*****
- Stage: Series G
- Total Funding till date: $284M
- Employee Count: 517 as on Jun 30, 2026
- Investors: Harmony Venture Partners, T. Rowe Price and 32 Others
- Latest Funding Round: Conventional Debt, Jun 21, 2022, $*****
- Highlight: Editors' Pick
3. Ocient
Provider of a big data analytics platform. It enables users to capture big data from different data sources and store data in the form of terabytes and petabytes. It allows users to analyze big data and helps organizations and individuals to improve business performance.
Key facts about Ocient
- Founded Year: 2016
- Location: Chicago (United States)
- Stage: Series B
- Total Funding till date: $208M
- Employee Count: 241 as on Jun 30, 2026
- Investors: Zelkova Ventures, Greycroft and 26 Others
- Latest Funding Round: Series B, Apr 22, 2025, $*****
- Highlight: Editors' Pick
_1551769784760.png?format=webp&height=120&width=120){kind=logo}
Developer of gene therapies for treating chronic and age-related diseases. The company's pipeline include RJB-0402 (liver-directed FGF21 for metabolic diseases), RJB-01, RJB-02, and RJB-03, with early focus on canine therapies before human translation.
Key facts about Rejuvenate Bio
- Founded Year: 2018
- Location: San Diego (United States)
- Stage: Series A
- Total Funding till date: $34M
- Employee Count: 16 as on Jun 30, 2026
- Investors: Digitalis Ventures, VCapital and 12 Others
- Latest Funding Round: Series A, Jun 03, 2026, $*****
- Highlight: Editors' Pick
Reformulating oncology drugs for treating late stage solid tumors. The company uses its DfuseRx platform to reformulate existing drugs to target late stage solid tumors. Currently, Intensity is testing its lead candidate in animal models for a number of different cancer indications, including colon cancer and breast cancer.
Key facts about Intensity Therapeutics
- Founded Year: 2012
- Location: Westport (United States)
- Stage: Public
- Total Funding till date: $21M
- Employee Count: 13 as on Jun 30, 2026
- Investors: Batterson Venture Capital, Fastforward Innovations and 3 Others
- Latest Funding Round: Series B, Nov 02, 2018, $*****
- Highlight: Public
VCapital's Year-on-Year Investment Trends
VCapital has invested in 24 companies over the last 10 years, with an average of 1 new investment annually in the last 10 years. As of Jun 2026, it has made 1 investment in this year. Its most recent first time investment was in Avenda Health and most recent follow-on round was in Rejuvenate Bio.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 1 | 1 |
2025 | 0 | 0 | 0 |
2024 | 0 | 1 | 1 |
2023 | 0 | 1 | 1 |
2022 | 3 | 0 | 3 |
2021 | 2 | 0 | 2 |
2020 | 0 | 0 | 0 |
2019 | 1 | 0 | 1 |
2018 | 1 | 1 | 2 |
2017 | 1 | 0 | 1 |
VCapital's Investments by Stage
VCapital has made 5 investments in Series A stage with an average round size of $7.46M, 2 investments in Series B stage with an average round size of $18M, 1 investment in Seed stage with an average round size of $7.25M and 1 investment in Series C stage.Stage of entry | No. of Investments |
|---|---|
Series A | 5 |
Series B | 2 |
Seed | 1 |
Series C | 1 |
Note: We have considered here, only first round of investments
VCapital's Investments by Sector
VCapital has a diverse portfolio, with companies operating in the High Tech, Enterprise Applications, HealthTech, Life Sciences and Vertical SaaS. Notably, it has invested in 22 Tech companies, 21 Enterprise (B2B) companies, 10 Software companies and at least 7 companies focusing on Saas.Sector | No. of Investments |
|---|---|
High Tech | 7 |
Enterprise Applications | 4 |
HealthTech | 4 |
Life Sciences | 4 |
Vertical SaaS | 3 |
Others | 10 |
Note: We have considered here, only first round of investments
VCapital's Investments by Geography
VCapital has made most investments in United States (8), followed by China where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 8 |
China | 1 |
Note: We have considered here, only first round of investments
VCapital's recent investments
VCapital has made 1 investments in 2026 so far - Rejuvenate Bio.Here are the most recent investments by VCapital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Jun 03, 2026 | United States | Series A | 5310 | [+4] | |
May 28, 2024 | United States | Series A | 8514 | ||
Apr 11, 2023 | United States | Series B | 7141 | [+4] | |
Aug 25, 2022 | United States | Series B | 9865 | ||
Aug 25, 2022 | United States | Series B | 9342 | [+7] |
Unicorns in VCapital's Portfolio
VCapital has 1 unicorn in its portfolio - Lookout. The most recent unicorn in their portfolio is Lookout which became a unicorn in 2014, 11 years before VCapital first invested in it.Here is a list of unicorns in VCapital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
70 | Provider of mobile endpoint security solutions against phishing and malware | 2007 | San Francisco | Series G | fghpwei |
IPOs and Publicly Listed companies in VCapital's Portfolio
3 of VCapital's portfolio companies have become public. Intensity Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jun 2023 at marketcap of $65.5M and Beyond got listed on the New York Stock Exchange (NYSE).Here are VCapital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jun 30, 2023 | Jun 28, 2016 | Series A | 4266 | |
May 31, 2002 | - | - | 6135 | |
Nov 26, 1997 | - | - | 1837 |
Acquired companies in VCapital's Portfolio
7 companies from VCapital's portfolio have been acquired. The most recent acquisition was AOL in Oct 2025 by Bending Spoons for $*****.Here are VCapital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 29, 2025 | - | - | 1759 | |
Jul 18, 2025 | Aug 25, 2022 | Series B | 4637 | |
Jun 08, 2021 | - | - | 6983 | |
Aug 19, 2019 | - | - | 4448 | |
Feb 22, 2018 | - | - | 5123 |
Team profile of VCapital
VCapital has a team of 7 members including 3 Partners located in United States. VCapital's team does not sit on the board of any company as of now.Here is a list of all team members in VCapital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Chicago | - | ||
Partner | Chicago | - | ||
Partner | Chicago | - |
Co-investors of VCapital
Over the past 10 years, 76 investors have co-invested in VCapital's portfolio companies. This includes funds and angels.
- Invested before VCapital: NIH, HHS and 22 others have invested in rounds before VCapital. There are 2 companies where NIH has invested before VCapital and 2 companies where HHS has invested before VCapital.
- Top Co-investors of VCapital: 26 investors entered a company along with VCapital. These include investors like KdT Ventures (1 company).
- Invested after VCapital: A total of 26 investors have invested in VCapital's portfolio after their investments. Top Investors include CIRM (1 company), Merck Animal Health (1 company) and Connecticut Innovations (1 company).
Recent News related to VCapital
•
Rejuvenate Bio Secures $6 Million in Financing Led by VCapitalMassinvestor•Jun 08, 2026•VCapital, Rejuvenate Bio, Merck Animal Health, Merck and 1 other
•
•
VCI Global to acquire licensed fund manager in Malaysia’s Labuan
Seeking Alpha•Jul 16, 2025•V Capital, VCapital
•
VCI Global to Acquire Licensed Fund Manager in Malaysia to Launch Bitcoin FundBenzinga•Jul 16, 2025•V Capital, VCapital
•
Raydiant Oximetry Attracts $7.5 Million in New FundingMedical Product Outsourcing•Jul 24, 2024•Raydiant Oximetry, Cross Border Impact Ventures, March of Dimes, RH Capital and 2 others
•
Arctic Xiongxin Receives Investment from V Capital.EqualOcean•Jun 13, 2024•XiongXin Technology, VCapital
•
Raydiant Oximetry Raises $7.5M in Extension Series AFinSMEs•Jun 05, 2024•Raydiant Oximetry, Cross Border Impact Ventures, RH Capital, Global Health Impact Network and 2 others
•
Claroty Secures $100 Million in Strategic Growth FinancingPR Newswire•Mar 06, 2024•Claroty, Delta-v Capital, AllianceBernstein, Standard Industries and 14 others
•
China's Coherent Biopharma raises $100mAsian Venture Capital Journal•May 15, 2023•Coherent Biopharma, HM Capital, Yunfeng Capital, VCapital and 3 others
•
SentiAR Announces Close of $8.5 million Series B FinancingAiThority•Apr 12, 2023•SentiAR, Genesis, MedVenture Partners, TechWald Holding and 4 others
